Attachment 8 - Data Table Templates (Amendment 1).xls
XLS spreadsheet 245 KB Posted
- Attached to
- Fixed Income Investment Services (Amendment 2)
- Solicitation number
- 16PBGC25R0062
- Issued by
-
Pension Benefit Guaranty Corporation
About this file
Attachment 8 is a comprehensive Excel data table template for a fixed income investment services solicitation by the Pension Benefit Guaranty Corporation (PBGC). The template consists of 15 detailed tables designed to capture extensive investment performance, organizational, and financial information from potential investment service providers. The tables request data across multiple years (from 6/30/20 to 6/30/25) on key metrics including monthly returns, total assets under management, employee demographics, investment staff composition, portfolio characteristics, returns, risk statistics, and client account details.
The solicitation (16PBGC25R0062) is a two-phase Request for Proposals (RFP) seeking fixed income investment services that can deliver total returns exceeding benchmark portfolios over a full market cycle. Offerors must be fully registered in the System for Award Management (SAM) and will be evaluated in Phase 1, with successful candidates invited to proceed to Phase 2. The RFP is open to all capable firms registered to do business with the U.S. Government, with the goal of selecting investment service providers who can demonstrate consistent performance, robust organizational structure, and the ability to manage fixed income portfolios effectively.
View the file
Other files
Show all 21
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Table 1
| Firm Name: | ||||||
| Product Name: | ||||||
| Benchmark Name: | ||||||
| Round to two decimal points. | ||||||
| Monthly Returns (%) | Rolling 60 month periods | Rolling period # | IR for Rolling 60 month period | |||
| Month | Portfolio | Benchmark | Geometric Excess Return (%) | |||
| Average IR |
&L&F &A&R&T &D
Table 2
| Firm Name: | ||||||
| Product Name: | ||||||
| 6/30/25 | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
| Total assets under management (U.S. $ in mils.) | ||||||
| Total Fixed Income AUM, U.S. ($ in mils.) | ||||||
| Total Fixed Income US Public Pensions AUM (all Fixed Income products, U.S. $ in mils.) | ||||||
| Total Fixed Income US Corporate Pensions AUM (all Fixed Income products, U.S. $ in mils.) | ||||||
| Total Fixed Income AUM in separate accounts that are $50M or greater in size (all Fixed Income products, U.S. $ in mils.) | ||||||
| Average Fixed Income Account Size | ||||||
| # FI Accounts gained | ||||||
| $ FI Gained | ||||||
| # FI Accounts lost | ||||||
| $ FI Lost |
&L&F &A&R&T &D
Table 3
| Firm Name: | |||||
| Product Name: | |||||
| Employees | 6/30/25 | 6/30/24 | 6/30/23 | 6/30/22 | # Left in the past 3 years |
| Executive Mgmt. (non-invest. staff) | |||||
| Investment Professionals | |||||
| Operational Risk Assessment Staff | |||||
| Marketing/Client Service | |||||
| Back Office | |||||
| IT | |||||
| Administrative | |||||
| Other: Specify | |||||
| TOTAL EMPLOYEES |
&L&F &A&R&T &D
Table 4
| Firm Name: | |||
| Product Name: | |||
| Location | Function Performed at Location | # of Employees | # Investment Professionals |
| City, State, Country |
&L&F &A&R&T &D
Table 5
| Firm Name: | |||||||
| Product Name: | |||||||
| 6/30/25 | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | Left Past 3 Yrs. | |
| Portfolio Managers | |||||||
| Research Staff/Analysts | |||||||
| Total Investment Staff | |||||||
| Total Fixed Income Employees |
&L&F &A&R&T &D
Table 6
| Firm Name: | |||||||
| Product Name: | |||||||
| Name | Role | Total Years of Experience | Years With Firm | Years With Subject Product | Education2/Degree/Year | School | Professional Designation |
| Note 1: Indicate whether individual has responsibilities for products other than the subject products. | |||||||
| Note 2: Most advanced degree only. |
&L&F &A&R&T &D
Table 7
| Firm Name: | ||||||||||||||
| Product Name: | ||||||||||||||
| Benchmark Name: | ||||||||||||||
| Date (Quarter End) | Effective Duration | Effective Convexity | Option Adjusted Spread | Yield to Maturity | Average Coupon | Average Quality (Moody’s) | Number of Holdings | Key Rate Duration 0-2 yrs | Key Rate Duration 3yr | Key Rate Duration 5yr | Key Rate Duration 10yr | Key Rate Duration 20yr | Key Rate Duration 30yr | |
| Portfolio | ||||||||||||||
| Benchmark |
&L&F &A&R&T &D
Table 8
| Firm Name: | ||||||||||||||||
| Product Name: | ||||||||||||||||
| Benchmark Name: | ||||||||||||||||
| Date (Quarter End) | Treasuries | Govt Related - Agencies | Govt Related - Local Auth | Govt Related -Sovereign | Govt Related – Supranational | Corporate – Industrial | Corporate – Utility | Corporate – Financial | Securitized - CMBS | Securitized – ABS | Securitized – Covered | Securitized – US MBS | Other | State the name of the largest component of 'Other' | Total | |
| Portfolio | ||||||||||||||||
| Benchmark |
&L&F &A&R&T &D
Table 9
| Firm Name: | |||
| Product Name: | |||
| Benchmark Name: | |||
| Quarterly Returns | |||
| Quarter end | Portfolio | Benchmark | Alpha |
&L&F &A&R&T &D
Table 10
| Firm Name: | |||||||||||
| Product Name: | |||||||||||
| Benchmark Name: | |||||||||||
| Country | 6/30/25 | 6/30/24 | 6/30/23 | ….. | ….. | ….. | ….. | ….. | ….. | ….. | |
| Portfolio | Country 1 | ||||||||||
| Country 2 | |||||||||||
| Country 3 | |||||||||||
| Region 1 | |||||||||||
| ….. | |||||||||||
| Country 4 | |||||||||||
| Country 5 | |||||||||||
| Country 6 | |||||||||||
| Region 2 | |||||||||||
| …. | |||||||||||
| Total | |||||||||||
| Benchmark | Country 1 | ||||||||||
| Country 2 | |||||||||||
| Country 3 | |||||||||||
| Region 1 | |||||||||||
| ….. | |||||||||||
| Country 4 | |||||||||||
| Country 5 | |||||||||||
| Country 6 | |||||||||||
| Region 2 | |||||||||||
| …. | |||||||||||
| Total |
&L&F &A&R&T &D
Table 11
| Firm Name: | |||||||
| Product Name: | |||||||
| Period | Gross Return (%) | Net Return (%) | Benchmark Return (%) | Number of Portfolios | Tracking Error (%) | Total Composite Assets ($ Millions) | Total Firm Assets ($ Millions) |
| Since Inception | |||||||
| YTD (as of 6/30/2025) | |||||||
| 2024 | |||||||
| 2023 | |||||||
| 2022 | |||||||
| 2021 | |||||||
| 2020 | |||||||
| 2019 | |||||||
| 2018 | |||||||
| 2017 | |||||||
| 2016 | |||||||
| 2015 | |||||||
| 2014 |
&L&F &A&R&T &D
Table 12
| Firm Name: | |||||||||||
| Product Name: | |||||||||||
| Calendar years | |||||||||||
| Annualized Returns | Year-to-Date (6/30/2025) | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
| High | |||||||||||
| Low | |||||||||||
| Difference |
&L&F &A&R&T &D
Table 13
| Firm Name: | ||||
| Product Name: | ||||
| Benchmark Name: | ||||
| Risk Statistics | 3 Years Ended 6/30/2025 | 5 Years Ended 6/30/2025 | 10 Years Ended 6/30/2025 | Since Inception |
| Portfolio Return (Gross of fees) | ||||
| Benchmark Return | ||||
| Alpha | ||||
| Beta | ||||
| R2 | ||||
| Up-Market Capture | ||||
| Down-Market Capture | ||||
| Standard Deviation | ||||
| Tracking Error | ||||
| Information Ratio |
&L&F &A&R&T &D
Table 14
| Firm Name: | ||||||
| Product Name: | ||||||
| 6/30/25 | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | |
| (a) Total assets managed in the subject product (U.S.$ in mils.) | ||||||
| Total # of Accounts | ||||||
| Average Account Size | ||||||
| Assets of the largest separate accounts (U.S.$ in mils.) | ||||||
| Assets of all separate accounts > $50M (U.S. $ in mils.) | ||||||
| # Accounts gained | ||||||
| $ Gained | ||||||
| # Accounts lost | ||||||
| $ Lost | ||||||
| (b) Total assets managed in the subject product for U.S. tax-exempt clients ($ in mils.) | ||||||
| Total # of Accounts | ||||||
| Average Account Size | ||||||
| # Accounts gained | ||||||
| $ Gained | ||||||
| # Accounts lost | ||||||
| $ Lost |
&L&F &A&R&T &D
Table 15
| Firm Name: | ||||
| Product Name: | ||||
| Client Name | Client Type | Tax-exempt (Y/N) | Date of Inception | Market Value (06/30/2025) |
&L&F &A&R&T &D
File details come from the government source that posted it. Updated .